[3H]AL-5848 ([3H]9β-(+)-fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin o study the pharmacology and autoradiographic localization of the FP receptor

Journal of Pharmacy and Pharmacology

Volumn 51, Issue 6, 1999, Pages 685-694

  Sharif, N A ^a   Davis, T L ^a   Williams, G W ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; 9BETA FLUPROSTENOL; CLOPROSTENOL; FLUPROSTENOL; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR; TRAVOPROST; UNCLASSIFIED DRUG; PROSTAGLANDIN F; PROSTAGLANDIN F2ALPHA RECEPTOR;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CATTLE; CELL STRAIN 3T3; CILIARY MUSCLE; CONTROLLED STUDY; CORPUS LUTEUM; DISSOCIATION CONSTANT; GRANULOSA CELL; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; NONHUMAN; RECEPTOR BINDING; RETINA; SCATCHARD PLOT; SPHINCTER PUPILLAE MUSCLE; VASCULAR SMOOTH MUSCLE; ANIMAL; DOSE RESPONSE; METABOLISM; MIDDLE AGED; MOUSE; RAT; STEREOISOMERISM;

3T3 CELLS; ADULT; AGED; ANIMALS; AUTORADIOGRAPHY; BINDING SITES; CATTLE; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICE; MIDDLE AGED; PROSTAGLANDINS F, SYNTHETIC; RATS; RECEPTORS, PROSTAGLANDIN; STEREOISOMERISM;

EID: 0032587372     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357991772989     Document Type: Article

References (44)

1. Abdel-Latif, A. A. (1995) Phosphoinositide and arachidonic acid signalling systems in the mammalian iris. Prog. Retinal Eye Res. 14: 75-107
2. Abramovitz, M., Adam, M., Boie, Y., Grygorczyk, R., Rushmore, T. H., Funk, C. D., Bastien, L., Sawyer, N., Rochette, C., Sliptz, D. M., Metters, K. M. (1995) Human prostanoid receptors: cloning and characterization. Adv. Prostaglandins Thromb. Leuk. Res. 23: 499-504
3. Andersen, N. H., Ramwell, P. W. (1974) Biological aspects of prostaglandins. Arch. Intern. Med. 133: 30-50
4. Armstrong, R. A., Lawrence, R. A., Jones, R. L., Wilson, N. H., Collier, A. (1989) Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors. Br. J. Pharmacol. 97: 657-668
5. Bito, L. Z. (1997) Prostaglandins: a new approach to glaucoma management with a new intriguing side-effect. Surv. Ophthalmol. 41 (Suppl. 22): S1-S14
6. 1C-adrenoceptors: studies in the isolated perfused kidney of rat. Br. J. Pharmacol. 115: 283-294
7. Bowen, W. P., Jerman, J. (1995) Nonlinear regression using spreadsheets. Trends Pharmacol. Sci. 16: 413-417
8. Chegini, N., Lei, Z. M., Rao, C. V., Hansel, W. (1991) Cellular distribution and cycle phase dependency of gonadotropin and eicosanoid binding sites in bovine corpora lutea. Biol. Reproduction 45: 506-513
9. Chen, J., Champa-Rodriguez, M. L., Woodward, D. F. (1995) Identification of a prostanoid FP receptor population producing endothelium-dependent vasorelaxation in the rabbit jugular vein. Br. J. Pharmacol. 116: 3035-3041
10. Chen, W., Andon, T., Bhattacherjee, P., Paterson, C. (1997) Intracellular calcium mobilization following prostaglandin receptor activation in human ciliary muscle cells. Curr. Eye Res. 16: 847-853
11. i) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 22: 3099-3108
12. Coleman, R. A., Smith, W. L., Narumiya, S. (1994) VIII. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46: 205-229
13. 2 receptor. J. Clin. Invest. 64: 586-590
14. 2α binding sites in the bovine iris ciliary body.. Invest. Opthalmol. Vis. Sci. 34: 2237-2245
15. 2+ in bovine luteal cells. Proc. Natl Acad. Sci. USA 84: 3728-3732
16. Davis, T. L., Sharif N. A. (1999) Quantitative autoradiographic visualization and pharmacology of FP-prostaglandin receptors in human eyes using the novel phosphor-imaging technology. J. Ocular Pharmacol. Ther. (in press)
17. Fernandes, B., Crankshaw, D. (1995) Functional characterization of the DP receptor in human myometrium. Eur. J. Pharmacol. 283: 73-81
18. Goh, Y., Kishino, J. (1994) Pharmacological characterization of prostaglandin-related ocular hypotensive agents. Jpn J. Ophthalmol. 38: 236-245
19. Goh, Y., Hotehama, Y., Mishima, H. K. (1995) Characterization of ciliary muscle relaxation induced by various agents in cats. Invest. Ophthalmol. Vis. Sci. 36: 1188-1192
20. Griffin, B. W., Williams, G. W., Crider, J. Y., Sharif, N. A. (1997) FP prostaglandin receptors mediating inositol phosphate generation and calcium mobilization in Swiss 3T3 cells: a pharmacological study. J. Pharmacol. Exp. Ther. 281: 845-854
21. Griffin, B. W., Magnino, P. E., Pang, I.-H., Sharif, N. A. (1998) Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization. J. Pharmacol. Exp. Ther. 286: 411-418
22. 2α, receptor in corpora lutea. In: Samuelsson, B., Paoletti, R. (eds) Advances in Prostaglandin and Thromboxane Research, Vol. 1, Raven Press, New York, pp 235-246
23. Hellberg, M., Sallee, V., Mclaughlin, M., Sharif, N. A., Desantis, L. M., Dean, T. R., Zinke, P. (1998) Preclinical efficacy of AL-6221, a potent and selective FP prostaglandin agonist. Invest. Ophthalmol. Vis. Sci. 39 (Suppl. 4): Abstr. 1961
24. 2α specific binding in bovine corpora lutea: comparison with luteolytic effects. Prostaglandins 10: 313-331
25. 2 binding sites in the human eye. Br. J. Ophthalmol. 76: 210-213
26. McPherson, G. A. (1983) A practical computer based approach to the analysis of radioligand binding experiments. Computer Prog. Biomed. 17: 107-114
27. Narumiya, S. (1994) Prostanoid receptors: structure, function, and distribution. In: Goetzl, E. J., Lewis, R. A., Rola-Pleszczynski, M. (eds) Cellular Generation, Transport, and Effects of Eicosanoids: Biological Roles and Pharmacological Intervention, The New York Academy of Sciences, New York, pp 126-138
28. Niswender, G. D., Nett, T. M. (1988) Corpus luteum and its control. In: Knobll, E., Neil, J. (eds) The Physiology of Reproduction, Raven Press, New York, pp 489-525
29. 2α receptor messenger RNA and protein in the cynomolgus monkey eye. Invest. Ophthalmol. Vis. Sci. 37: 716-726
30. Ogletree, M. L., Allen, G. T. (1992) Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles. J. Pharmacol. Exp. Ther. 260: 789-794
31. 2α receptor. J. Biol. Chem. 269: 3881-3886
32. Sallee, V., Mclaughlin, M., Griffin, B. W., Sharif, N. A. (1998) Correlation of results from preclinical experimental models used for evaluation of FP prostaglandin agonists for therapy of glaucoma. Invest. Ophthalmol. Vis. Sci. 39 (Suppl. 4): Abstr. 4274
33. Senior, J., Marshall, K., Sangha, R., Clayton, J. K. (1993) In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br. J. Pharmacol. 108: 501-506
34. Sharif, N. A. (1996) Quantitative autoradiographic methods. In: Toga, A. W., Mazziota, J. C. (eds), Brain Mapping: The Methods, Academic Press, New York, pp 115-144
35. Sharif, N. A., Hughes, J. (1989) Discrete mapping of brain mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors. Peptides 10: 499-522
36. 3H]GR65630 binding. Br. J. Pharmacol. 102: 919-925
37. 3 and FP receptor binding sites in bovine corpus luteum: characterization and correlation with functional data. J. Pharmacol. Exp. Ther. 286: 1094-1102
38. 2α analogue. Adv. Prostaglandin. Thrombox. Leukotr. Res. 23: 513-518
39. 2α analog, on aqueous humour dynamics in human eyes. Ophthalmol. 100: 1297-1304
40. Upham, L. V., Englert, D. F. (1998) Radionuclide imaging. In: L'Lannunziata, M. (ed.) Handbook of Radioactivity Analysis, Academic Press, New York, pp 647-692
41. 2, and their esters in glaucomatous monkey eyes. Invest. Ophthalmol. Vis. Sci. 31: 2466-2470
42. Weinreb, R. N., Kashiwagi, K., Kashiwagi, F., Tsukahara, S., Lindsey, J. D. (1997) Prostaglandins increase matrix metalloprosteinase release from human ciliary smooth muscle cells. Invest. Ophthalmol. Vis. Sci. 38: 2770-2772
43. 2α to membranes of rat corpora lutea. Mol. Cell. Endocrinol. 13: 25-34
44. 2α and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. Exp. Eye Res. 63: 305-310